Pyrazolam Facts
Depressant;
Description
Pyrazolam is a synthetic depressant of the benzodiazepine class. It enhances GABA, the brain's main calming neurotransmitter, producing anxiety suppression with less sedation than most benzodiazepines.[1]
Subjective effects include anxiety relief, mild sedation, muscle relaxation, and cognitive slowing.[2] The experience is defined by what it removes — anxiety recedes cleanly, without the euphoria, heavy sedation, or mental fog typical of most benzodiazepines, making the effect highly sensitive to baseline anxiety level.[3]
Pyrazolam produces high abuse liability with regular use, and withdrawal can include seizures.[4] The mechanism places a ceiling on overdose risk from pyrazolam alone, but combining it with opioids, alcohol, or other depressants removes that ceiling.[5]
Dose and durationby route · individual sensitivity varies
Starts in 10 – 15 minLasts 5 – 8 hoursAfter-effects 1 – 6 hours
Body and dependence
- Acute toxicity
- Low
- Chronic toxicity
- Low
- Physical dependence
- High
- Psychological dependence
- High
- Withdrawal
- Severe · medical supervision
- Compulsive redosing
- Moderate
Tolerance
- Builds
- Rapid
- Fully resets after
- 10.5 days
- Carries over to
- benzodiazepines;
zolpidem; zaleplon; barbiturates; alcohol
Effectslikely at a common dose
- Perception
- none likely · 3 possible, including Visual acuity suppression, Spatial disorientation
- Body
- Sedation;
Muscle relaxation; +8 possible, including Motor control impairment, Dizziness, Nystagmus (eye wobbles) - Thinking
- Cognitive impairment;
+15 possible, including Memory suppression, Decision impairment, Information processing suppression - Feeling
- Anxiety suppression;
+2 possible - Self
- none likely · 3 possible, including Craving
- Time
- none likely · 1 possible, including Temporal disorientation
Who shouldn't take it
Combinations60 recorded
Seek help immediately if
- Extreme drowsiness — can't stay awake or be roused
- Confusion, slurred speech, severe loss of coordination
- Slow, shallow, or irregular breathing
- Unconsciousness / unresponsive; limp, floppy body
- Blue lips or fingertips
- Vomiting while sedated (choking / aspiration risk)
- Cold, clammy skin; weak pulse
What to do
- Try to wake them — shout, firm sternal rub
- If unresponsive or breathing is impaired, call emergency services
- Place them in the recovery position — critical, they can choke on vomit
- Monitor breathing continuously; be ready to give rescue breaths / CPR
- Never leave them alone to "sleep it off"
- Do not give other drugs, stimulants, or more depressants
Most depressant overdoses resolve with airway protection, breathing support, and monitoring. The danger is respiratory depression and choking on vomit — sharply worse when combined with opioids or alcohol. GHB/GBL overdoses often involve sudden deep unconsciousness and may self-resolve, but airway protection is essential.
988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE
References
- [1]^Not specified in web search results (2026) In vitro γ-aminobutyric acid A (GABAA) receptor activity and binding interactions at the α+/γ2– interface of 53 prescription and designer benzodiazepines — Communications Chemistry (Nature) doi:10.1038/s42004-026-02001-x
- [2]
- [3]^Abouchedid R, Gilks T, Dargan PI, Archer JRH, Wood DM (2018) Assessment of the Availability, Cost, and Motivations for Use over Time of the New Psychoactive Substances-Benzodiazepines Diclazepam, Flubromazepam, and Pyrazolam-in the UK — Journal of Medical Toxicology doi:10.1007/s13181-018-0659-3
- [4]^Manchester KR, Lomas EC, Waters L, Dempsey FC, Maskell PD (2018) The emergence of new psychoactive substance (NPS) benzodiazepines: A review. — Drug testing and analysis doi:10.1002/dta.2211
- [5]^Lehmann S, Sczyslo A, Froch-Cortis J, Rothschild MA, Thevis M, Andresen-Streichert H, Mercer-Chalmers-Bender K (2019) Organ distribution of diclazepam, pyrazolam and 3-fluorophenmetrazine — Forensic Science International doi:10.1016/j.forsciint.2019.109959